Insider Transactions in Q2 2024 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 10
2024
|
Artal International S.C.A. |
BUY
Exercise of conversion of derivative security
|
Indirect |
57,546,100
+29.7%
|
-
|
|
Apr 28
2024
|
Christopher J Sobecki Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,032
+4.59%
|
-
|
|
Apr 28
2024
|
Judith L Swain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,032
+14.24%
|
-
|
|
Apr 28
2024
|
Philippe Amouyal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,032
+3.13%
|
-
|
|
Apr 28
2024
|
Sam L Barker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,032
+8.39%
|
-
|
|
Apr 28
2024
|
Raymond Debbane Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,032
+0.59%
|
-
|
|
Apr 28
2024
|
Robert J Md Lefkowitz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,032
+14.24%
|
-
|